Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Excellos, Vitalant Enter Strategic Partnership | Contract Pharma

What are you searching for?

Sign in
Collaborations & Alliances

Excellos, Vitalant Enter Strategic Partnership

Focused on supporting development and delivery of new cell therapies and addressing challenges in bringing therapies to patients.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Excellos Inc., a cell therapy CDMO, partnered with Vitalant, a nonprofit blood and biotherapies healthcare organization, which includes an investment by Vitalant, for cell sourcing, testing, and lab services. It also includes collaboration with the Vitalant Innovation Center, which provides research and translational development expertise for new products and services.

The strategic partnership is focused on supporting organizations to develop and deliver new cell therapies and addresses major challenges in bringing therapies to patients. Cell therapy development teams will now have access to larger and better geographically distributed donors that are well-characterized for aspects including metabolic and effector function profiles. This improves therapeutic potency and reduces manufacturing costs, while reducing clinical response variability.

David Wellis, Ph.D., Chief Executive Officer of Excellos, said, “This is a great opportunity for Excellos to extend its collection network across the country and to collaborate with Vitalant in several areas, including testing services and research and development at their state-of-the-art Innovation Center. Additionally, Vitalant’s investment brings financial capital to accelerate the launch of new Excellos products and services, including donor characterization through our Excellos 360 platform.”

“Through our partnership with Excellos and other innovators, Vitalant can leverage our unique capabilities and expertise to transform healthcare,” said Becky Cap, Vitalant’s Senior Vice President of Biotherapies. “We look forward to working with Excellos to help develop new technologies and therapies that improve patient access and outcomes.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics